
APPLIED BIOSYSTEMS BY THERMO FISHER SCIENTIFIC, QPCR
Give your cell and gene therapy development an edge
With a comprehensive ecosystem of real-time PCR (qPCR) and digital PCR (dPCR) solutions for applications that span discovery through large-scale commercial manufacturing, we streamline your workflows without compromising on quality. The Applied Biosystems™ QualTrak™ BioPharma offering is a carefully curated selection of high-quality qPCR master mixes, assays and instruments that deliver consistently high performance, enabling you to be confident in your data. With our support, you can minimize time spent repeating or verifying work and simplify drug filings to optimize development timelines.
Featured QualTrak products and services:
- Applied Biosystems QuantStudio 6 and 7 Pro Real-Time PCR Systems
- Applied Biosystems TaqPath Assays and Probes
- Applied Biosystems TaqPath Master Mixes
- Applied Biosystems QuanStudio Absolute Q Digital PCR System
- Applied Biosystems QuanStudio Absolute Q Viral Titer Digital PCR Assays
- Instrument Hardware Qualification Services (IQ/OQ/PQ or IPV)
- Analytical Validation, Computer System Validation, and Bioinformatics Consulting
Streamlined development. Simplified compliance.
With Thermo Fisher Scientific, you have the support you need to push your therapeutic development strategies a step further. TaqPath assays and master mixes are manufactured at ISO-certified facilities following cGMP protocols and include readily available compliance documentation to support experimental report preparation for regulatory submissions. Coupled with 21 CFR 820 compliant instruments and software backed by world-class instrument service and support, this comprehensive suite of tools provides everything needed to streamline biologics development and accelerate delivery of live-saving, breakthrough therapies.
ABOUT THERMO FISHER SCIENTIFIC
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
PODCASTS
- The Potential Of RNA Exon Editing With Ascidian Therapeutics' Romesh Subramanian, Ph.D.
- Automating Processes To Scale CGT Manufacturing With PA Consulting's Paolo Siciliano
- The Why Behind In-House Manufacturing With Sangamo's Andy Ramelmeier
- 2023 Market Outlook with AdBio and ISCT's Miguel Forte
- CMC And Scale Up With Mustang Bio's Robert Sexton
- An Interview with Dr. Peter Marks
- Why Are NK Cells Necessary To Move Immunotherapies Forward?
- The Future Of iPSCs With BlueRock Therapeutics' CEO Seth Ettenberg
- Manufacturing at the Point of Care with Orgenesis' CEO Vered Caplan
- Capstan Therapeutics' CEO Laura Shawver On In Vivo Cell Engineering
- PepGen's SVP Head Of Clinical Development On Delivery Of Oligonucleotide Therapies
- BridgeBio's Chief Regulatory Affairs Officer Adora Ndu on PDUFA VII Reauthorization
- Inside RNAi With Arrowhead Pharmaceuticals' Javier San Martin
- Planning For Manufacturing Capacity With Kite Pharma's Will Junker
- Commercialization Learnings With Novartis Gene Therapies' President Chris Fox
- A Stem Cell-Derived Treatment For T1D
- Best Practices For Partnering With A CDMO
- An Interview With Dr. Carl June
- Inside Gamma Delta T Cells with TC BioPharm’s CEO, Bryan Kobel
- Moving On From AAV With Poseida Therapeutics' CEO, Mark Gergen
- Inside The New Hybrid Roles For Cell Therapy Clinical Trials With Immatics' Michael Mehler
- Allogeneic RNA Cell Therapy Program With Cartesian Therapeutics' Dr. Metin Kurtoglu
- Gene Therapy's Commercial Manufacturing Issues with Encoded Therapeutics' Andy Stober
- Inside CAR-T Therapy For Ovarian Cancer with Anixa Biosciences' Amit Kumar, Ph.D.
CONTACT INFORMATION
Applied Biosystems by Thermo Fisher Scientific, qPCR
5823 Newton Drive
Carlsbad, CA 92008
UNITED STATES
QPCR - RESOURCES FOR QUALITY CONTROL
- A Stem Cell-Derived Treatment For T1D
- An Interview with Dr. Carl June
- Best Practices For Partnering With A CDMO
- Commercialization Learnings With Novartis Gene Therapies' President Chris Fox
- Considerations For Cell Therapy Development And Manufacturing
- Inside RNAi With Arrowhead Pharmaceuticals' Javier San Martin
- Leverage qPCR And dPCR To Streamline Biologics Development
- Planning For Manufacturing Capacity With Kite Pharma's Will Junker
- QualTrak Real-Time PCR And Digital PCR Ecosystem For Streamlined Biologics Development
- QuantStudio 6 And 7 Pro Real-Time PCR Systems
- TaqPath Assays And Probes
- QuantStudio Absolute Q Digital PCR System
- Instrument Hardware Qualification Services (IQ/OQ/PQ or IPV)
- Analytical Validation, Computer System Validation, And Bioinformatics Consulting
- TaqPath qPCR And RT-qPCR Master Mixes
- QuanStudio Absolute Q Viral Titer Digital PCR Assays
- Uniformity Of Gene Expression Measurements On The QuantStudio 7 Pro Real-Time PCR System
CGT - RESOURCES FOR MANUFACTURING
- A Closed Solution For T Cell Isolation And Activation
- Cell Therapy: Streamline The Path From Discovery To Commercialization
- Accelerating Cell Therapy Development Through Collaboration
- Gene Therapy: From Set-Up To Scale-Up
- Your Cell And Gene Therapy Journey: From Discovery To Commercialization
- Expanding The Cell And Gene Therapy Manufacturing Workflow
- Gene Therapy: From Set-Up To Scale-Up
- Scale Up And Process Development: Ask The Experts
- Cell Therapy Handbook: Considerations For Cell Therapy Development And Manufacturing
- Cell Therapy: Optimizing The Vein-To-Vein Workflow
- Thermo Fisher And UCSF Cell Therapy Strategic Alliance
- An Innovative Approach Towards Standardizing Cell Therapy Manufacturing
- Overcoming Cell Therapy Manufacturing Challenges With Closed, Modular And Automated Solutions
- Cell Therapy Workflow: Integrated Solutions From Collection To Delivery
- Connect To The Future Of Gene Therapy
- Connect To The Future Of Cell Therapy
- Approaches To Implementing Automation In Cell Therapy Technology
- Scalable AAV Manufacturing—Addressing Challenges Across The Workflow
- Innovations In Gene Therapy: Building The Complete Solution For Viral Vector Production
- Decentralized Manufacturing: Enabling Scalable And Cost-Effective Point Of Care For Cell And Gene Therapies
- Current And Future State Of T Cell Therapy Manufacturing
- Autologous CAR T Cell Manufacturing Using A Semiautomatic, Closed, Modular Workflow